Custom Recombinant Protein Production Services Market Companies

Custom Recombinant Protein Production Services Market, By Expression System (Mammalian, Bacteria, Insect, Yeast, and Others), By End User (Research Institutes, Biotechnology and Pharmaceutical Companies, Contract Research Organizations and Others), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Sep 2023

Code : CMI2737

Pages :207

Formats :

Excel and PDF

Industry : Biotechnology

Leading Companies

Global Custom Recombinant Protein Production Services Market - Key Players

Major players operating in the global custom recombinant protein production services market include GenScript Biotech Corporation, SignalChem Biotech Inc., Crown Bioscience, Inc., BPS Bioscience Inc., Novoprotein, Applied Biological Materials (abm) Inc., Eurofins Pharma Discovery Services, Abgent (WuXi AppTec Company), OriGene Technologies, Inc., Kempbio, Inc., Trenzyme GmbH, Sino Biological Inc., Aragen Bioscience, a GVKBIO Company, LakePharma, Inc., Inc., Proteos Inc., Icosagen AS, Novus Biological LLC, Proteogenix, Premas Biotech, ATUM, and Aldevron.

Key Developments

In July 2021, Atlas Antibodies, a provider of research antibodies based in Stockholm, Sweden, announced the acquisition of Evitria, a Biotechnology company. This transformative acquisition brings together a leading provider of highly validated research antibodies and a front-runner in the field of custom recombinant antibody expression.

In September 2021, Aviva Systems Biology, a company providing antibodies, immunoassay kits, and recombinant proteins for life science research, announced the launch of its new Protein on Demand semi-custom recombinant protein portfolio for life scientists conducting basic research and preclinical studies. The Protein on Demand portfolio of over 300,000 proteins allows rapid access to small- to mid-scale production of customized proteins for research teams.

Increasing inorganic activities such as acquisitions and collaborations: The market players are focused on adopting strategies such as acquisitions and collaborations to gain a strong foothold in the global market. For instance, in December 2021, Thermo Fischer Scientific Inc., a Biotechnology company acquired PeproTech, Inc., which is a developer and manufacturer of recombinant proteins. This acquisition will help Thermo Fischer Scientific Inc. strengthen its recombinant protein portfolio.